Last updated: May 13, 2022
Sponsor: University of Washington
Overall Status: Active - Recruiting
Phase
N/A
Condition
Opioid Use Disorder
Treatment
N/AClinical Study ID
NCT05327166
STUDY00012599
R01DA051462
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Aged 18 years or older
- Moderate or Severe OUD based on the Structured Clinical Interview for DSM Disorders (SCID)
- Currently have a phone or method of contact
- Able to provide a phone number and one additional piece of contact information
Exclusion
Exclusion Criteria:
- Incarcerated or under arrest
- Non-English speaking
- Live beyond a 50 mile radius of Harborview Medical Center
- Require active resuscitation in the ED or other clinical area at the time of ResearchAssistant (RA) approach
- Are receiving palliative care services or hospice care for a chronic illness such asmetastatic cancer
- Are in the ED or hospital for a primary psychiatric emergency such as suicidalideation or attempt and require emergent evaluation by a Psychiatrist
- Receiving chronic opioid therapy (COT) defined as prescription opioids for most daysout of the last 90 days for a chronic pain condition
- In the ED for sexual assault
- Enrolled or eligible for state-funded or hospital-funded care coordination programbased on high utilization of the ED
Study Design
Total Participants: 500
Study Start date:
April 12, 2022
Estimated Completion Date:
December 31, 2026
Study Description
Connect with a study center
Harborview Medical Center
Seattle, Washington 98104
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.